Eli Lilly Reports Earnings on Oct. 29. Here's Why the Retatrutide Story Matters More Than the Quarter.
Eli Lilly's next big growth driver could be bigger than Zepbound.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.